ArticleClinical interventions in aging2019
Comparison of three criteria for potentially inappropriate medications in Chinese older adults.
Article in Clinical interventions in aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Potentially Inappropriate Medication Use in Older Adults: Concordance Among the Chinese and AGS/Beers and STOPP Criteria.Journal of clinical medicine · 2026Article
- Potentially Inappropriate Prescription and Its Association with Index Hospitalization: A Multicenter, Cross-Sectional Study Using TIME Criteria.Drugs & aging · 2026Observational
- Updating the potentially inappropriate medication (PIM)-China criteria for 2024: a Delphi consensus study for improved medication safety in older adults.International journal of clinical pharmacy · 2026Article
- Association between potentially inappropriate medications and 30-day outcomes among hospitalized older adults with reduced physiologic reserve: a retrospective cohort study.Frontiers in pharmacology · 2026Article
- Assessment of the potential of drug-drug interactions among population-based oldest-old people in Turkiye.PeerJ · 2025Article
- Association of potentially inappropriate medications with prognosis among older patients with non-small cell lung cancer.BMC geriatrics · 2024Article
- Frequency of Single or Combined Anticholinergic Medication Usage as Potentially Inappropriate Medications among the Oldest-Old Age Subgroup.Psychiatry and clinical psychopharmacology · 2024Article
- Article
- Knowledge, attitude, and practice of medical interns and postgraduate residents on American Geriatric Society updated Beers criteria.Journal of education and health promotion · 2023Article
- Evaluation of potentially inappropriate medications for the elderly according to beers, STOPP, START, and Chinese criteria.Frontiers in pharmacology · 2023Article
- Overuse of medications in low- and middle-income countries: a scoping review.Bulletin of the World Health Organization · 2023Article
- Nutritional Status and Potentially Inappropriate Medications in Elderly.Journal of clinical medicine · 2022Article
- Potentially inappropriate medications in older Chinese outpatients based on the Beers criteria and Chinese criteria.Frontiers in pharmacology · 2022Article
- Prescription of Potentially Inappropriate Medication Use in Older Cancer Outpatients With Multimorbidity: Concordance Among the Chinese, AGS/Beers, and STOPP Criteria.Frontiers in pharmacology · 2022Article
- Potentially Inappropriate Medication Among People With Dementia in China: A Nationwide Cross-Sectional Study.Frontiers in pharmacology · 2022Article
- A machine learning-based risk warning platform for potentially inappropriate prescriptions for elderly patients with cardiovascular disease.Frontiers in pharmacology · 2022Article
- Article
- Potentially inappropriate medications based on TIME criteria and risk of in-hospital mortality in COVID-19 patients.Revista da Associacao Medica Brasileira (1992) · 2022Article
- Article
- Profile of Prescription Medication in an Internal Medicine Ward.Healthcare (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to compare the prevalence of potentially inappropriate medications (PIMs) among Chinese aged patients using the Beers criteria of 2015, the Screening Tool of Older Persons' Prescriptions (STOPP) of 2014 and the criteria of PIMs for older adults in China (Chinese criteria), and to identify the correlates of the PIMs' use.
methodsA retrospective, cross-sectional study was conducted among geriatric patients at Beijing Chao-Yang Hospital between January 2018 and March 2018. Three criteria (the Beers criteria of 2015, the STOPP criteria of 2014 and the Chinese criteria) were used to detect PIMs. A multivariate logistic regression analysis was carried out to determine factors associated with the use of PIMs. Leading PIMs for each set of criteria were also listed. The concordance among the three PIM criteria was calculated using kappa tests.
resultsTotally, 863 inpatients aged ≥65 years were included. The prevalence of patients receiving at least one PIM was 80.2%, 58.1% and 44.0% according to the Chinese criteria, 2015 Beers criteria and 2014 STOPP criteria, respectively. The Beers and the STOPP criteria indicated a moderate coherence, whereas the Chinese criteria showed poor concordance with the other two criteria. Proton-pump inhibitors in the Beers and STOPP criteria and clopidogrel in the PIM-Chinese accounted for most leading PIMs. The most important factor associated with PIM use by all three sets of criteria was the number of prescribed medications.
conclusionData showed a high PIM prevalence among older adults in China, which was associated with the number of prescribed medications. The Chinese criteria had the highest detection rate but a poor concordance with the Beers and STOPP criteria (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.